Affinity Asset Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Affinity Asset Advisors, LLC
- $735 Million
- Q2 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 110,000 shares of MDGL stock, worth $24 Million. This represents 4.19% of its overall portfolio holdings.
Number of Shares
110,000
Previous 115,000
4.35%
Holding current value
$24 Million
Previous $30.7 Million
0.35%
% of portfolio
4.19%
Previous 4.45%
Shares
12 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
21.9MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$541 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$448 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$430 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$417 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$403 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.72B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...